Skip to main content
. 2020 Aug 27;56(2):419–433. doi: 10.1038/s41409-020-01031-w

Fig. 4. Treatment-related survival separated by severe aGvHD status in discovery cohort and joint replication cohorts comparing patients with peritransplant 1,25-dihydroxyvitamin-D3 serum levels above and below the cutoff 139.5 pM.

Fig. 4

Shown are Kaplan–Meier curves comparing patients with peritransplant 1,25-dihydroxyvitamin-D3 serum levels (day −2 to 7) above versus below the cutoff 139.5 pM separately for the group of patients without severe aGvHD (aGvHD 3–4) and the group of patients with severe aGvHD a in the discovery cohort and b in the joint replication cohorts.